HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Louis Tong Selected Research

Meibomian Gland Dysfunction

10/2022Profile of tear lipid mediator as a biomarker of inflammation for meibomian gland dysfunction and ocular surface diseases: Standard operating procedures.
12/2020Changes of tear lipid mediators after eyelid warming or thermopulsation treatment for meibomian gland dysfunction.
1/2020A Review on Evidence-Based Treatments for Meibomian Gland Dysfunction.
10/2018Tear Lactoferrin and Features of Ocular Allergy in Different Severities of Meibomian Gland Dysfunction.
1/2018Tear eicosanoids in healthy people and ocular surface disease.
1/2017TFOS DEWS II Diagnostic Methodology report.
4/2016Longitudinal Changes in Tear Evaporation Rates After Eyelid Warming Therapies in Meibomian Gland Dysfunction.
12/2014A Randomized, Controlled Treatment Trial of Eyelid-Warming Therapies in Meibomian Gland Dysfunction.
9/2014Longitudinal changes in tear fluid lipidome brought about by eyelid-warming treatment in a cohort of meibomian gland dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Louis Tong Research Topics

Disease

55Dry Eye Syndromes (Dry Eye Syndrome)
04/2022 - 10/2005
18Inflammation (Inflammations)
10/2022 - 07/2008
13Pterygium
01/2018 - 07/2008
9Meibomian Gland Dysfunction
10/2022 - 09/2014
7Glaucoma
04/2022 - 09/2011
6Myopia
03/2019 - 01/2002
4Necrosis
01/2019 - 06/2014
4Cataract (Cataracts)
12/2017 - 11/2012
3Wounds and Injuries (Trauma)
01/2022 - 01/2013
3Thyroid Diseases (Thyroid Disease)
11/2018 - 11/2012
3HIV Infections (HIV Infection)
04/2017 - 12/2016
2Sjogren's Syndrome (Sjogren Syndrome)
04/2022 - 11/2021
2Fibrosis (Cirrhosis)
10/2020 - 01/2020
2Blepharitis
01/2020 - 01/2018
2Telangiectasis (Telangiectasia)
10/2018 - 11/2012
2Hypersensitivity (Allergy)
10/2018 - 12/2016
2Atrophy
10/2018 - 01/2018
2Rheumatoid Arthritis
12/2014 - 11/2012
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2011 - 03/2009
1Graft vs Host Disease (Graft-Versus-Host Disease)
04/2022
1Compassion Fatigue
01/2021
1Blister (Bulla)
10/2020
1Cicatrix (Scar)
11/2019
1Ulcer
11/2019
1Metaplasia
07/2019
1Hyperglycemia
01/2019
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2019
1Graves Ophthalmopathy
11/2018
1Coloboma (Colobomas)
01/2018

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
07/2019 - 07/2008
14LipidsIBA
10/2022 - 01/2011
14CytokinesIBA
11/2021 - 01/2011
11Fluorescein (Funduscein)FDA LinkGeneric
01/2020 - 11/2012
10Ophthalmic Solutions (Eye Drops)IBA
02/2022 - 01/2012
8Biomarkers (Surrogate Marker)IBA
10/2022 - 11/2009
7tear proteinsIBA
11/2018 - 03/2009
5Lubricant Eye Drops (Artificial Tears)IBA
01/2020 - 11/2012
5LubricantsIBA
01/2017 - 11/2012
4Adrenal Cortex Hormones (Corticosteroids)IBA
10/2020 - 09/2014
4EnzymesIBA
07/2019 - 07/2008
3Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2021 - 09/2014
3Matrix Metalloproteinases (MMPs)IBA
07/2019 - 02/2012
3AtropineFDA LinkGeneric
03/2019 - 12/2006
3LactoferrinIBA
10/2018 - 11/2009
3Transcription Factors (Transcription Factor)IBA
01/2014 - 01/2011
2AlkaliesIBA
01/2022 - 07/2012
2Mitomycin (Mitomycin-C)FDA LinkGeneric
10/2020 - 11/2019
2Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 09/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2019 - 01/2017
2Interleukin-17 (Interleukin 17)IBA
07/2019 - 01/2018
2Calcium-Binding ProteinsIBA
11/2018 - 01/2014
2ProlactinIBA
11/2018 - 11/2009
2Pharmaceutical PreparationsIBA
12/2016 - 10/2011
2Antiglaucoma AgentsIBA
01/2015 - 09/2011
2S100 Proteins (S 100 Protein)IBA
01/2014 - 01/2009
2Small Interfering RNA (siRNA)IBA
06/2013 - 01/2013
2Retinaldehyde (Retinal)IBA
10/2011 - 11/2007
2Mydriatics (Cycloplegics)IBA
11/2007 - 07/2004
14-hexyloxyaniline (HOA)IBA
02/2022
1PlasticsIBA
01/2022
1EmulsionsIBA
11/2021
1ProteomeIBA
01/2021
1AminoglycosidesIBA
10/2020
1AlkanesIBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
07/2019
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
07/2019
1HLA-DR Antigens (HLA-DR)IBA
07/2019
1Interleukin-8 (Interleukin 8)IBA
07/2019
1Chemokine ReceptorsIBA
07/2019
1Membrane Proteins (Integral Membrane Proteins)IBA
07/2019
1CaspasesIBA
01/2019
1Bimatoprost (Lumigan)FDA Link
01/2019
1Latanoprost (Xalatan)FDA Link
01/2019
1ProstaglandinsIBA
01/2019
1Environmental Pollutants (Pollutants, Environmental)IBA
06/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2018
1OzoneIBA
06/2018
1Interleukin-4 (Interleukin 4)IBA
01/2018
1Terpenes (Terpenoids)IBA
01/2018
15-hydroxy-6,8,11,14-eicosatetraenoic acidIBA
01/2018
1Leukotriene B4IBA
01/2018
1Macular PigmentIBA
01/2018
1Long Noncoding RNAIBA
01/2018
1EicosanoidsIBA
01/2018

Therapy/Procedure

12Therapeutics
01/2021 - 01/2014
6Contact Lenses
04/2022 - 11/2012
3Laser In Situ Keratomileusis (LASIK)
01/2021 - 11/2012
3Punctal Plugs
10/2017 - 01/2016
2Trabeculectomy (Trabeculoplasty)
10/2020 - 01/2017
2Slit Lamp
10/2018 - 11/2012
2Complementary Therapies (Alternative Medicine)
01/2018 - 01/2012
2Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2018 - 01/2012
2Lenses
05/2016 - 01/2005
1Acupuncture Therapy
01/2021
1Sutures (Suture)
01/2021
1Refractive Surgical Procedures
01/2021
1Corneal Cross-Linking
01/2021
1Percutaneous Collagen Induction
10/2020
1Investigational Therapies (Experimental Therapy)
11/2019
1Secondary Prevention
01/2019